Quadrature Capital’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$457K Buy
+6,172
New +$440K ﹤0.01% 1428
2026
Q2
– Sell
-3,321
Closed -$206K – 2081
2026
Q1
$206K Buy
+3,321
New +$209K ﹤0.01% 1111
2024
Q3
– Sell
-8,521
Closed -$574K – 1411
2024
Q2
$574K Sell
8,521
-23,789
-74% -$1.62M 0.01% 618
2024
Q1
$2.29M Buy
32,310
+20,671
+178% +$1.55M 0.04% 282
2023
Q4
$985K Sell
11,639
-1,724
-13% -$143K 0.02% 446
2023
Q3
$1.16M Buy
13,363
+7,510
+128% +$693K 0.02% 385
2023
Q2
$546K Buy
5,853
+1,805
+45% +$170K 0.01% 562
2023
Q1
$384K Buy
+4,048
New +$372K 0.01% 617
2022
Q2
– Sell
-6,914
Closed -$619K – 980
2022
Q1
$619K Buy
6,914
+426
+7% +$39.2K 0.02% 358
2021
Q4
$652K Buy
+6,488
New +$662K 0.03% 316

Other funds holding UTMD

Quadrature Capital's UTMD Position: Q3 2026 in Review

Quadrature Capital opened a new position in Utah Medical Products (UTMD) in Q3 2026: 6,172 shares worth $457K. The stake represents ﹤0.01% of the portfolio and ranks #1428 among its holdings. This is a return to the name: Quadrature Capital previously reported a position in UTMD as recently as Q1 2026.

Quadrature Capital first reported a position in UTMD in Q4 2021 and has held it in 10 quarters since. The position peaked at $2.29M in Q1 2024. 128 funds tracked by Wall St. Rank hold UTMD as of Q3 2026.

  • Quadrature Capital held 6,172 shares of Utah Medical Products worth $457K as of Q3 2026.
  • Utah Medical Products was a new Quadrature Capital position in Q3 2026.
  • Utah Medical Products made up ﹤0.01% of Quadrature Capital's portfolio in Q3 2026, its #1428 holding.
  • Quadrature Capital first reported a position in Utah Medical Products in Q4 2021 and has held it in 10 quarters since.
  • Quadrature Capital's Utah Medical Products position peaked at $2.29M in Q1 2024.
  • 128 funds tracked by Wall St. Rank held Utah Medical Products as of Q3 2026.

Based on Quadrature Capital's 13F filing for Q3 2026, filed 13 Nov 2026.